XNAS · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-06-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-06-18. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-06-04. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-21. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Moderna (MRNA) had 1 Form 144 pre-sale notice filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refe…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 6/15/2026 | Hoge Stephen | President | OPTION_EXERCISE | -16,110 | — | — |
| 6/15/2026 | Hoge Stephen | President | OPTION_EXERCISE | -37,226 | — | — |
| 6/15/2026 | Hoge Stephen | President | SELL | -53,336 | $51 | $2,739,870 |
| 6/15/2026 | Hoge Stephen | President | OPTION_EXERCISE | 16,110 | $19 | $308,507 |
| 6/15/2026 | Hoge Stephen | President | OPTION_EXERCISE | 37,226 | $19 | $712,878 |
| 6/5/2026 | Mock James M | Chief Financial Officer | OPTION_EXERCISE | -11,798 | — | — |
| 6/5/2026 | Mock James M | Chief Financial Officer | TAX_WITHHOLD | -5,705 | $52 | $294,321 |
| 6/5/2026 | Mock James M | Chief Financial Officer | OPTION_EXERCISE | 11,798 | — | — |
| 6/5/2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | -11,798 | — | — |
| 6/5/2026 | Klinger Shannon Thyme | Chief Legal Officer | TAX_WITHHOLD | -5,705 | $52 | $294,321 |
| 6/5/2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | 11,798 | — | — |
| 6/4/2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | -3,471 | — | — |
| 6/4/2026 | Klinger Shannon Thyme | Chief Legal Officer | SELL | -3,471 | $50 | $173,550 |
| 6/4/2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | 3,471 | $31 | $107,462 |
| 6/1/2026 | Hoge Stephen | President | OPTION_EXERCISE | -9,282 | — | — |
| 6/1/2026 | Hoge Stephen | President | TAX_WITHHOLD | -4,488 | $47 | $211,789 |
| 6/1/2026 | Hoge Stephen | President | OPTION_EXERCISE | 9,282 | — | — |
| 6/1/2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | -2,165 | — | — |
| 6/1/2026 | Klinger Shannon Thyme | Chief Legal Officer | TAX_WITHHOLD | -1,047 | $47 | $49,408 |
| 6/1/2026 | Klinger Shannon Thyme | Chief Legal Officer | OPTION_EXERCISE | 2,165 | — | — |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 6/18/2026 | SAGAN PAUL | — | 25,770 | SEC |
| 6/15/2026 | Hoge Stephen | — | 53,336 | SEC |
| 6/4/2026 | Klinger Shannon Thyme | — | 3,471 | SEC |
| 5/21/2026 | Flagship Pioneering, LLC | — | 9,263 | SEC |
| 5/15/2026 | Hoge Stephen | — | 53,336 | SEC |
| 5/8/2026 | SAGAN PAUL | — | 36,759 | SEC |
| 5/1/2026 | Hussain Abbas | — | 5,682 | SEC |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| 6/30/2026 | — | — | — | — | SEC |